EU Public Health Alerts

The European Centre for Disease Prevention and Control (ECDC) is actively tracking several emerging public health threats across the Union. Currently, the ECDC monitors a rise in drug-resistant gonorrhoea, with ceftriaxone-resistant strains reported in multiple countries, underscoring an urgent need for enhanced surveillance and new treatments. The agency also warns that prolonged heatwaves, a direct consequence of climate change, are escalating the risk of infectious diseases such as dengue and West Nile virus, prompting the ECDC to scale up monitoring and response actions. Concurrently, while Europe has made progress on hepatitis B and C prevention, it remains set to miss the 2030 elimination target due to persistent prevention gaps.

These developments matter profoundly for citizens and businesses. The increasing prevalence of drug-resistant infections and climate-sensitive diseases directly impacts public health and healthcare systems, potentially leading to higher treatment costs and reduced productivity. Businesses, especially in the tourism and healthcare sectors, face direct consequences from outbreaks or widespread health alerts. The ECDC's calls for intensified action and broader access to interventions, as seen with hepatitis, highlight the need for a robust, coordinated EU-wide response to safeguard public health and economic stability.

Looking ahead, EU public health policy will increasingly focus on adapting to climate change impacts and strengthening disease surveillance capabilities. The ECDC's emphasis on intensified action, close cooperation between member states, and research into new treatment options points to a future where preventative measures, early warning systems, and coordinated cross-border responses will be paramount. Expect continued EU investment in public health infrastructure and research to tackle persistent challenges like hepatitis elimination and emerging threats driven by environmental changes.